日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer.

组蛋白甲基转移酶 KMT2D 是去势抵抗性前列腺癌谱系可塑性和治疗反应的关键介质。

Kittane Srushti, Ladewig Erik, Li Taibo, Love Jillian R, Blawski Ryan, Gao Yangzhenyu, Arruabarrena-Aristorena Amaia, Zhao Peihua, Dalrymple Susan L, Liu Huayang, Guo Xinyu, Sallaku Mirna, Kelkar Nachiket, Garcia-Martinez Liliana, Carmona Sanz Javier, Chen Wanlu, Stoudmann Candice, Baldino Laura, Razavi-Mohseni Milad, Kalemi Ingrid, Beer Michael A, Castel Pau, Brennen W Nathaniel, Scaltriti Maurizio, Morey Lluis, Cocco Emiliano, Ji Hongkai, Chan Ho Man, Battle Alexis, Leslie Christina S, Karthaus Wouter R, Toska Eneda

Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cells

RET 和 SRC 双重靶向治疗对 RET 融合阳性癌细胞具有协同作用。

Son, Juhyeon; Remsing Rix, Lily L; Fang, Bin; Welsh, Eric A; Bremer, Nicole V; Foglizzo, Valentina; Roa, Paola; Sigcha-Coello, Nickole; Liao, Yi; Haura, Eric B; Drilon, Alexander; Koomen, John M; Cocco, Emiliano; Rix, Uwe

CIPHER-seq enables intracellular multimodal profiling of cytokine responses in single immune cells

CIPHER-seq技术能够对单个免疫细胞内的细胞因子反应进行多模态分析。

Bhalgat, Avni; Micin, Katarina; Affer, Maurizio; Ayupe, Ana C; Gomez, Isabella; Schatz, Jonathan H; Stelekati, Erietta; Williams, Sion; Komanduri, Krishna; Wieder, Eric; Cocco, Emiliano; Taylor, Justin

Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers

抑制NR2F2可恢复内分泌难治性乳腺癌的激素治疗反应

Cai, Yanyan; Zhao, Peihua; Wu, Fan; Zhao, Huiyong; Shao, Hong; Marra, Antonio; Patel, Payal; O'Connell, Elizabeth; Fink, Emma; Miele, Matthew M; Li, Zhuoning; De Stanchina, Elisa; Cocco, Emiliano; Razavi, Pedram; Toska, Eneda; Fanning, Sean W; Xu, Guotai; Sablina, Anna A; Scaltriti, Maurizio; Chandarlapaty, Sarat

Responsiveness of different MET tumour alterations to type I and type II MET inhibitors.

不同MET肿瘤改变对I型和II型MET抑制剂的反应性

Murciano-Goroff Yonina R, Foglizzo Valentina, Chang Jason, Rekhtman Natasha, Sisk Ann Elizabeth, Gibson Jamie, Judka Lia, Clemens Kristen, Roa Paola, Ahmed Shaza Sayed, Bremer Nicole V, Binaco Courtney Lynn, Muzungu Sherifah Kemigisha, Rodriguez Estelamari, Merrill Madeline, Sgroe Erica, Repetto Matteo, Stadler Zsofia K, Berger Michael F, Yu Helena A, Toska Eneda, Kannan Srinivasaraghavan, Verma Chandra S, Drilon Alexander, Cocco Emiliano

A Radiomic-based model to predict the depth of myometrial invasion in endometrial cancer on ultrasound images

基于放射组学的模型预测子宫内膜癌超声图像中肌层浸润深度

Arezzo, Francesca; Fanizzi, Annarita; Mancari, Rosanna; Cocco, Emiliano; Bove, Samantha; Comes, Maria Colomba; Gianciotta, Mariangela; Lanza, Giorgia; Lopez, Salvatore; Cazzato, Gerardo; Silvestris, Erica; Vitale, Elsa; Vizza, Enrico; Cormio, Gennaro; Massafra, Raffaella; Loizzi, Vera

Patient-Derived-Xenografts in Mice: A Preclinical Platform for Cancer Research

小鼠体内患者来源的异种移植模型:癌症研究的临床前平台

Cocco, Emiliano; de Stanchina, Elisa

Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents

Zurletrectinib 是一种新一代 TRK 抑制剂,对具有靶向耐药性的 NTRK 融合阳性肿瘤具有强大的颅内活性。

Roa, Paola; Foglizzo, Valentina; Harada, Guilherme; Repetto, Matteo; Kulick, Amanda; de Stanchina, Elisa; de Marchena, Michelle; Auwardt, Supipi; Sayed Ahmed, Shaza; Bremer, Nicole Virginia; Yang, Soo-Ryum; Feng, Yangbo; Zhou, Chao; Kong, Norman; Liang, Ruixia; Xu, Haipeng; Zhang, Bin; Bardelli, Alberto; Toska, Eneda; Ventura, Andrea; Drilon, Alexander; Cocco, Emiliano

Mutations in the Serine/Threonine Kinase BRAF: Oncogenic Drivers in Solid Tumors

丝氨酸/苏氨酸激酶BRAF的突变:实体瘤的致癌驱动因素

Roa, Paola; Bremer, Nicole Virginia; Foglizzo, Valentina; Cocco, Emiliano

Rare molecular subtypes of lung cancer

肺癌的罕见分子亚型

Harada, Guilherme; Yang, Soo-Ryum; Cocco, Emiliano; Drilon, Alexander